Option Care Health (OPCH)
(Real Time Quote from BATS)
$30.04 USD
-1.57 (-4.97%)
Updated Aug 5, 2024 10:12 AM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Option Care (OPCH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$39.13 | $43.00 | $36.00 | 23.79% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Option Care comes to $39.13. The forecasts range from a low of $36.00 to a high of $43.00. The average price target represents an increase of 23.79% from the last closing price of $31.61.
Analyst Price Targets (8 )
Broker Rating
Option Care currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on eight recommendations.
Of the nine recommendations deriving the current ABR, nine are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 8 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/1/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
7/31/2024 | William Blair | Matt Larew | Strong Buy | Strong Buy |
7/25/2024 | Barrington Research | Michael J Petusky | Strong Buy | Strong Buy |
7/16/2024 | JMP Securities | Constantine Kyriakos Davides | Not Available | Strong Buy |
3/31/2024 | Goldman Sachs | Jamie Perse | Strong Buy | Strong Buy |
3/4/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 9 |
Average Target Price | $39.13 |
LT Growth Rate | 10.80% |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 72 of 253 |
Current Quarter EPS Est: | 0.31 |